Halper Sadeh Investigates Range Resources' EQT Sale and Three Other Deals

Halper Sadeh LLC is investigating Range Resources Corporation's sale to EQT Corporation for 0.987 shares of EQT common stock for each Range share, the investor rights law firm said in a GlobeNewswire release dated November 10, 2026. The firm said it is examining potential violations of federal securities laws or breaches of fiduciary duties tied to the proposed transaction.

Halper Sadeh's Range Resources and EQT Review

Halper Sadeh said Range shareholders are expected to own approximately 27% of the combined company once the transaction is completed. The firm said insiders may stand to receive substantial financial benefits not available to ordinary shareholders, and that the proposed transactions may contain terms that could limit superior competing offers. It said it may seek increased consideration, additional disclosures and information, or other relief and benefits on behalf of shareholders.

Range Resources is an NYSE-listed company. Range Resources reported third-quarter earnings of $175.3 million, or 75 cents per share, beating analyst estimates of 70 cents, with revenue of $842.8 million, according to Yahoo.

The same release names three other companies under investigation. Array Technologies, Inc. (NASDAQ: ARRY) is merging with Shoals Technologies Group, Inc., and Array shareholders are expected to own approximately 35% of the combined company upon closing. Surgery Partners, Inc. (NASDAQ: SGRY) is being sold to HealthSpan Partners for $23.50 in cash per share. Lumentum Holdings Inc. (NASDAQ: LITE) is being sold to Marvell Technology, Inc. for 4.500 shares of Marvell common stock for each Lumentum share, with Lumentum shareholders expected to own approximately 33% of the combined company.

Halper Sadeh's Case History and Scale

According to akta.pro company records, Halper Sadeh was founded in New York in 2015 as a specialized investor rights law firm operating on a contingency-fee model. The same records list recoveries including $20 million in In re Galena Biopharma, Inc., Securities Litigation (D. Or.) and $23.5 million in Thomas v. Magnachip Semiconductor Corp. (N.D. Cal.). The firm's leadership includes founding partners Zachary Halper and Daniel Sadeh.

Earlier Halper Sadeh Investigations

Halper Sadeh announced on August 24, 2026 that it was investigating Werewolf Therapeutics, Beazer Homes USA, MarketAxess Holdings and CBIZ for potential securities law violations and fiduciary duty breaches, according to FinancialContent Business Page. On August 28, 2026, the firm said it was investigating VREX, BWMN, NATH and SYBX for possible securities law violations and fiduciary duty breaches, FinancialContent Business Page reported. The firm announced on September 8, 2026 that it was investigating Bio-Techne's sale to Merck, Colony Bankcorp's merger with First Reliance, and Auddia's merger with Thramann, according to FinancialContent Business Page.

What Comes Next for Range Shareholders

Halper Sadeh said shareholders can contact the firm to discuss their rights and options at no cost or obligation, and that it would handle any matter on a contingent fee basis, with clients not responsible for out-of-pocket payment of legal fees or expenses.